 |
 |
||||||||||||
Mapp Biopharmaceutical was founded in 2003 to develop novel pharmaceuticals for the prevention and treatment of infectious diseases, focusing on unmet needs in global health and biodefense. As Mapp's products transition to clinical evaluation, licenses are transferred to Mapp's commercialization partner, LeafBio. ZMapp™ Information SheetZMapp™ Frequently Asked QuestionsFebruary 6, 2015 at 8:30 AM - LeafBio, Inc. submitted an Investigational New Drug (IND) application for clinical evaluation of ZMapp™ to the Food and Drug Administration (FDA) on February 3, 2015. February 27, 2015 at 8:30 AM - Mapp Bio Clinical Trials Press Release 
Mapp Biopharmaceutical, Inc. 6160 Lusk Blvd. # C105 San Diego, CA 92121 phone: 858 625 0335 fax: 800 372 2176 admin@mappbio.com Media Inquiries media@mappbio.com FCOI Policy |
|
||||||||||||
| ©2012 Mapp Biopharmaceutical, Inc. All rights reserved. | |||||||||||||
